Smith & Nephew Acquires Healthpoint Biotherapeutics for $782M

London-based medical device company Smith & Nephew is buying Texas-based Healthpoint Biotherapeutics for $782 million, according to the Washington Post.

Advertisement

Healthpoint focuses on acute, chronic and burn-related wound care. The company hopes the acquisition will strengthen Smith & Nephew’s position in bioactive wound care.

Healthpoint and its 460 employees will continue to be based in Fort Worth.

More Articles on Devices:
Symmetry Surgical to Partner With Italian Device Maker Biocommerciale
Ulrich Releases Posterior Spine Stabilization Implant
Bioventus Leases $5M Office, Creates 44 Jobs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.